Custom Services Opportunity to upsell bespoke antibody services such as custom labeling (HRP/biotin), targeted immunizations, and recombinant monoclonals to clients running preclinical studies or translational research, leveraging ProSci's 28-year legacy and fast 2–6 month turnaround.

RUO Biosimilars Market expansion through RUO biosimilars aimed at cost-effective oncology and diagnostic research, appealing to labs seeking affordable alternatives without compromising quality, especially in CRO collaborations and early-stage development.

CRO Partnerships Strengthen and monetize collaborations with contract research organizations by offering bundled antibody solutions, QA/QC robust processes, and streamlined supply chains to support end-to-end research projects.

Diagnostic & Therapeutic Focus Target diagnostics developers and therapeutic researchers with end-to-end antibody support, including peptide design assistance and project-based customization, aligned with ProSci’s emphasis on assisting therapeutics and diagnostics tool development.

Growth & Visibility Leverage recent recognition and Genesee Scientific integration to pursue co-branding or distribution partnerships, expand global reach, and highlight rapid project success rates to attract new lab customers and increase market share.